Insulet Corp. Stock
Price
Target price
€215.80
€215.80
-0.050%
-0.1
-0.050%
€317.21
30.01.26 / Tradegate
WKN: A0MQX8 / Symbol: PODD / Name: Insulet / Stock / Healthcare Equipment & Supplies / Mid Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Insulet Corp. Stock
With only a change of -€0.100 (-0.050%) the Insulet Corp. price is nearly unchanged from yesterday.
The stock is an absolute favorite of our community with 45 Buy predictions and no Sell predictions.
With a target price of 317 € there is a positive potential of 46.9% for Insulet Corp. compared to the current price of 215.8 €.
So far the community has only identified positive things for Insulet Corp. stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".
Pros and Cons of Insulet Corp. in the next few years
Pros
?
M***** P*******
?
W********* I********* f** t** n*** y****
?
B****
Cons
?
C******** o* t** e**********
?
S********** s********
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Insulet Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Insulet Corp. | -0.050% | -6.092% | -11.630% | -19.807% | -11.630% | -18.196% | -1.820% |
| Icu Medical Inc. | -0.800% | -3.876% | 0.000% | -23.926% | 0.000% | -28.324% | -25.749% |
| Bio-Rad Labs Inc. A | -0.120% | -7.052% | -3.916% | -27.607% | -3.916% | -43.810% | -47.722% |
| Neogen Corp. | -1.720% | 3.012% | 39.024% | -22.973% | 39.024% | - | - |
Comments
Insulet (NASDAQ:PODD) had its "buy" rating reaffirmed by analysts at UBS Group AG.
Show more
Ratings data for PODD provided by MarketBeat
Insulet (NASDAQ:PODD) had its price target lowered by analysts at Truist Financial Corporation from $412.00 to $390.00. They now have a "buy" rating on the stock.
Show more
Ratings data for PODD provided by MarketBeat
Insulet (NASDAQ:PODD) is now covered by analysts at Evercore ISI. They set an "outperform" rating and a $370.00 price target on the stock.
Show more
Ratings data for PODD provided by MarketBeat
News
Is Insulet (PODD) the Future of Diabetes Management?
Explore the exciting world of Insulet (NASDAQ: PODD) with our contributing expert analysts in this Motley Fool Scoreboard episode. Check out the video below to gain valuable insights into market
Insulet (PODD) Q2 Revenue Jumps 33%
Insulet (NASDAQ:PODD), a medical device company specializing in wearable insulin delivery systems, released its second quarter 2025 earnings on August 7, 2025. The headline news was strong